Bright Minds Biosciences Inc (DRUG.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Operating Expenses | 1,625 | 791 | -235 | 558 | 1,699 |
| Operating Income | -1,625 | -791 | 235 | -558 | -1,699 |
| Other Income | 1,674 | 18 | -5 | -16 | 15 |
| Pre-tax Income | 50 | -773 | 230 | -574 | -1,684 |
| Net Income Continuous | 50 | -773 | 230 | -574 | -1,684 |
| Net Income | $50 | $-773 | $230 | $-574 | $-1,684 |
| EPS Basic Total Ops | 0.01 | -0.17 | 0.05 | -0.13 | -0.44 |
| EPS Basic Continuous Ops | 0.01 | -0.17 | 0.05 | -0.13 | -0.44 |
| EPS Diluted Total Ops | 0.01 | -0.17 | 0.05 | -0.13 | -0.44 |
| EPS Diluted Continuous Ops | 0.01 | -0.17 | 0.05 | -0.13 | -0.44 |
| EBITDA(a) | $-1,603 | $-772 | $253 | $-540 | $-1,681 |